Last reviewed · How we verify

KRG (Korea Red ginseng) — Competitive Intelligence Brief

KRG (Korea Red ginseng) (KRG (Korea Red ginseng)) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Herbal supplement / adaptogen. Area: General wellness / Traditional medicine.

marketed Herbal supplement / adaptogen General wellness / Traditional medicine Small molecule Live · refreshed every 30 min

Target snapshot

KRG (Korea Red ginseng) (KRG (Korea Red ginseng)) — Chuncheon Sacred Heart Hospital. Korean red ginseng contains ginsenosides and other bioactive compounds that enhance immune function, improve circulation, and reduce inflammation.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
KRG (Korea Red ginseng) TARGET KRG (Korea Red ginseng) Chuncheon Sacred Heart Hospital marketed Herbal supplement / adaptogen
American Ginseng root American Ginseng root Southern Illinois University marketed Herbal supplement / Adaptogen

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Herbal supplement / adaptogen class)

  1. Chuncheon Sacred Heart Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). KRG (Korea Red ginseng) — Competitive Intelligence Brief. https://druglandscape.com/ci/krg-korea-red-ginseng. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: